CH505565A - Tabakverarbeitungsverfahren - Google Patents
TabakverarbeitungsverfahrenInfo
- Publication number
- CH505565A CH505565A CH1017666A CH1017666A CH505565A CH 505565 A CH505565 A CH 505565A CH 1017666 A CH1017666 A CH 1017666A CH 1017666 A CH1017666 A CH 1017666A CH 505565 A CH505565 A CH 505565A
- Authority
- CH
- Switzerland
- Prior art keywords
- tobacco
- agent
- cigarettes
- deuterium
- acid
- Prior art date
Links
- 241000208125 Nicotiana Species 0.000 title claims abstract description 60
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 60
- 230000000711 cancerogenic effect Effects 0.000 title abstract description 20
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 40
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 36
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229910052805 deuterium Inorganic materials 0.000 claims abstract description 17
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 230000000391 smoking effect Effects 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 28
- 239000000779 smoke Substances 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 230000001419 dependent effect Effects 0.000 claims description 6
- 238000003672 processing method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 230000002411 adverse Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000010998 test method Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 15
- 231100000315 carcinogenic Toxicity 0.000 description 12
- 235000015165 citric acid Nutrition 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000011835 investigation Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 150000001975 deuterium Chemical group 0.000 description 2
- 125000004431 deuterium atom Chemical group 0.000 description 2
- -1 deuterium ion Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010061968 Gastric neoplasm Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000004265 Stomach Rupture Diseases 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 230000002533 cocarcinogenic effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 208000011581 secondary neoplasm Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/246—Polycyclic aromatic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/287—Treatment of tobacco products or tobacco substitutes by chemical substances by inorganic substances only
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Manufacture Of Tobacco Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1965B0082871 DE1517262A1 (de) | 1965-07-16 | 1965-07-16 | Verfahren zur beseitigung der krebserzeugenden eigenschaften des 3,4 - benzpyrens im zigarettentabak |
| US53363166A | 1966-03-11 | 1966-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH505565A true CH505565A (de) | 1971-04-15 |
Family
ID=25967609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1017666A CH505565A (de) | 1965-07-16 | 1966-07-13 | Tabakverarbeitungsverfahren |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | AT291444B (es) |
| CH (1) | CH505565A (es) |
| ES (1) | ES329209A1 (es) |
| IL (1) | IL26050A (es) |
-
1966
- 1966-06-28 IL IL2605066A patent/IL26050A/xx unknown
- 1966-07-13 CH CH1017666A patent/CH505565A/de not_active IP Right Cessation
- 1966-07-16 ES ES0329209A patent/ES329209A1/es not_active Expired
- 1966-07-18 AT AT688066A patent/AT291444B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL26050A (en) | 1971-02-25 |
| ES329209A1 (es) | 1967-09-01 |
| AT291444B (de) | 1971-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0756461B1 (de) | Tabakerzeugnisse oder tabakerzeugnissen ähnliche waren mit antioxidativ wirkenden naturstoffen und verfahren zur herstellung derselben | |
| DE3417586C2 (es) | ||
| DE2265372A1 (de) | Verfahren zur herstellung von rekonstituiertem tabak | |
| DE1517294A1 (de) | Tabakerzeugnis mit geringer Teererzeugung und Verfahren zu seiner Herstellung | |
| CH647534A5 (de) | Cyclodextrin-kamillen-inklusionskomplexe, verfahren zur herstellung der komplexe und die komplexe enthaltenden praeparate. | |
| DE1692759B2 (de) | Aromatisierter Tabak | |
| DE2206859A1 (de) | Tabakwaren mit verbessertem Geschmack und Verfahren zu ihrer Herstellung | |
| DD153571A5 (de) | Verfahren zur behandlung von rauchtabak zwecks schadstoffsenkung im rauch | |
| DE2919556A1 (de) | Tabakmischung, aus dieser hergestellte zigaretten, zigarren und pfeifentabake und verfahren zum behandeln von tabak | |
| DE68905657T2 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| CH505565A (de) | Tabakverarbeitungsverfahren | |
| DE1692895A1 (de) | Saeure enthaltender Tabakrauchfilterkoerper aus Celluloseacetat und Verfahren zu seiner Herstellung | |
| DE1692900A1 (de) | Tabakrauchmittel | |
| DE2505157C3 (de) | Aromatisierung von Tabakprodukten | |
| DE10085492B4 (de) | Antimonocytenaktivität von extrakten von Betelpfefferblättern | |
| DE1915785A1 (de) | Verfahren zur Verarbeitung von Tabak | |
| DE2256235A1 (de) | Verfahren zum behandeln von tabak | |
| DE943250C (de) | Verfahren zum Stabilisieren von antibiotisch wirksamen Inhaltsstoffen von Allium sativum | |
| DE1517321A1 (de) | Verfahren zur Behandlung von Tabak zwecks Verbesserung seiner Abraucheigenschaften und der Faerbung der Asche | |
| DE2944917C2 (de) | Verfahren zum Bearbeiten von Tabak | |
| DE2309152A1 (de) | Rauchgemisch | |
| DE835323C (de) | Verfahren zur Herstellung stabiler Metallsalzloesungen | |
| DE2916573A1 (de) | Arzneimittel und verfahren zu seiner herstellung | |
| DE194810C (es) | ||
| DE1517328B1 (de) | Verfahren zur Verbesserung eines Tabakproduktes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |